Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis-Reference-Cited by-同舟云学术

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

Published:2021-06-01 Issue:21 Volume:325 Page:2178
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Furuta Shunsuke¹,Nakagomi Daiki²,Kobayashi Yoshihisa³,Hiraguri Masaki⁴,Sugiyama Takao⁵,Amano Koichi⁶,Umibe Takeshi⁷,Kono Hajime⁸,Kurasawa Kazuhiro⁹,Kita Yasuhiko¹⁰,Matsumura Ryutaro¹¹,Kaneko Yuko¹²,Ninagawa Keita¹³,Hiromura Keiju¹⁴,Kagami Shin-ichiro¹⁵,Inaba Yosuke¹⁶,Hanaoka Hideki¹⁶,Ikeda Kei¹,Nakajima Hiroshi¹,Nagashima Kengo¹⁷,Kawasaki Yohei¹⁷,Ozawa Yoshito¹⁷,Someya Kokoro¹⁷,Kono Asako¹⁷,Kashiwakuma Daisuke¹⁷,Watanabe Hiroshi¹⁷,Nakashita Tamao¹⁷,Mimura Norihiro¹⁷,Oya Yoshihiro¹⁷,Fujiwara Michio¹⁷,Narita Ichiei¹⁷,Wada Yoko¹⁷,Nakatsue Takeshi¹⁷,Ogawa Noriyoshi¹⁷,Suzuki Daisuke¹⁷,Asako Kurumi¹⁷,Kikuchi Hirotoshi¹⁷,Uchida Shunya¹⁷,Fujigaki Yoshihide¹⁷,Sakairi Toru¹⁷,Maezawa Reika¹⁷,Kawashima Hirotoshi¹⁷,Matsuki Ayako¹⁷,Yamagata Mieko¹⁷,Ohta Yuichiro¹⁷,Sakai Ryota¹⁷,Ishii Tomonori¹⁷,Kawakami Atsushi¹⁷,Sumida Takayuki¹⁷,Watanabe Norihiko¹⁷,Atsumi Tatsuya¹⁷,Tanimura Shun¹⁷,Kumanogoh Atsushi¹⁷,Sugihara Takahiko¹⁷,Iwai Hideyuki¹⁷,Tanaka Yoshiya¹⁷,Komatsuda Atsushi¹⁷,Ito Kaori¹⁷,Shimojima Yoshihiro¹⁷,Sekigawa Iwao¹⁷,Takakuwa Yukiko¹⁷,Makino Yuichi¹⁷,Yoshimi Ryusuke¹⁷,Hayashi Taichi¹⁷,Otani Hiroshi¹⁷,

Affiliation:

1. Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan

2. Third Department of Internal Medicine, University of Yamanashi, Chuo, Japan

3. Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan

4. Allergy and Clinical Immunology Center, Japanese Red Cross Narita Hospital, Narita, Japan

5. Department of Rheumatology, Shimoshizu Hospital, National Hospital Organization, Yotsukaido, Japan

6. Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

7. Department of Internal Medicine, Matsudo City Hospital, Matsudo, Japan

8. Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

9. Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan

10. Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan

11. Department of Rheumatology, National Hospital Organization Chiba-East Hospital, Chiba, Japan

12. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

13. Department of Rheumatology, Endocrinology, and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

14. Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, Maebashi, Japan

15. Research Center for Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan

16. Clinical Research Center, Chiba University Hospital, Chiba, Japan

17. for the LoVAS Collaborators

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2780489/jama_furuta_2021_oi_210044_1621623369.62356.pdf

Reference32 articles.

1. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.;Yates;Ann Rheum Dis,2016